Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Peters, M.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(21 - 40 of 58)

Pages

Genome-wide association and functional studies identify a role for matrix Gla protein in osteoarthritis of the hand
An easy-to-use scoring index to determine severity of mitral regurgitation by 2D echocardiography in clinical practice
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control study
Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients
NOVEL SUSCEPTABILITY LOCI FOR OSTEOARTHRITIS OF THE HAND: CODING VARIANTS IN MGP AND ENPP3
Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors
The "OPTI-CLOT" trial
Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey
Inhibitor development and mortality in non-severe hemophilia A
Inhibitors in nonsevere haemophilia A: outcome and eradication strategies
Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic review
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)
Clinical presentation of inhibitor development in non-severe hemophilia A: half of patients have high titer inhibitors and present with bleeding complications
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Factor VIII gene (F8) mutation and inhibitor development in non-severe hemophilia A
RISE- response to DDAVP in moderate/mild haemophilia A patients: in search for determinants

Pages